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Abstract
Introduction: The purpose of this study was to investigate coplanar and non-
coplanar volumetric modulated arc therapy (VMAT) delivery techniques for
stereotactic ablative radiation therapy (SABR) to the lung. Methods: For ten
patients who had already completed a course of radiation therapy for early
stage lung cancer, three new SABR treatment plans were created using (1) a
coplanar full arc (FA) technique, (2) a coplanar partial arc technique (PA) and
(3) a non-coplanar technique utilising three partial arcs (NCA). These plans
were evaluated using planning target volume (PTV) coverage, dose to organs at
risk, and high and intermediate dose constraints as incorporated by radiation
therapy oncology group (RTOG) 1021. Results: When the FA and PA
techniques were compared to the NCA technique, on average the PTV coverage
(V54Gy) was similar (P = 0.15); FA (95.1%), PA (95.11%) and NCA (95.71%).
The NCA resulted in a better conformity index (CI) of the prescription dose
(0.89) when compared to the FA technique (0.88, P = 0.23) and the PA
technique (0.83, P = 0.06). The NCA technique improved the intermediate
dose constraints with a statistically significant difference for the D2cm and R50%
when compared with the FA (P < 0.03 and <0.0001) and PA (P < 0.04 and
<0.0001) techniques. The NCA technique reduced the maximum spinal cord
dose by 2.72 and 4.2 Gy when compared to the PA and FA techniques
respectively. Mean lung doses were 4.09, 4.31 and 3.98 Gy for the FA, PA and
NCA techniques respectively. Conclusion: The NCA VMAT technique provided
the highest compliance to RTOG 1021 when compared to coplanar techniques
for lung SABR. However, single FA coplanar VMAT was suitable for 70% of
patients when minor deviations to both the intermediate dose and organ at risk
(OAR) constraints were accepted.
Introduction
Stereotactic ablative radiation therapy (SABR) is the
delivery of a highly ablative radiation dose in a few
fractions. It was originally introduced for early stage lung
cancer patients who were deemed medically unfit for
surgery.1 SABR is commonly delivered using a high
number of coplanar and non-coplanar three-dimensional
conformal radiation therapy (3DCRT) beams. In a
previous single centre dosimetry comparison, the authors
demonstrated that a predominantly non-coplanar, 10
beam technique had the most favourable compliance with
ª 2016 The Authors. Journal of Medical Radiation Sciences published by John Wiley & Sons Australia, Ltd on behalf of
Australian Institute of Radiography and New Zealand Institute of Medical Radiation Technology.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License,
which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and
no modifications or adaptations are made.
23
the radiation therapy oncology group (RTOG) 1021
protocol.2,3 A highly non-coplanar beam arrangement
allowed for improved intermediate dose conformity and
organ at risk (OAR) sparing. However, the engagement of
a high number of couch rotations can extend the treatment
times to potentially unfavourable lengths.4 It has previously
been reported that for treatment times extending over
34 min that a baseline shift in tumour position of up to
5 mm can occur.5 Delivery times for lung SABR can vary
depending on the equipment used, fractional dose, patient
compliance and the delivery technique itself.
Volumetric modulated arc therapy (VMAT) is a novel
technique that delivers the dose whereas the linear
accelerator rotates continuously around the patient.6,7
The dose rate, gantry rotation speed and multileaf
collimator (MLC) positions are all variables that can be
altered whereas the machine is delivering the dose. Single
coplanar arcs have already been shown to reduce
treatment times for SABR to the lung when compared to
3DCRT, whereas achieving highly conformal dose
distributions.4 However, non-coplanar beam
arrangements improve the intermediate dose conformity,
which is one of the key dosimetry metrics for SABR.
Therefore, this study was designed to quantify any
benefits arising from non-coplanar VMAT when
compared to coplanar VMAT for SABR to the lung.
Methods
Institutional ethics approval was granted for this
retrospective study. Ten patients who were eligible for SABR
and had completed their course of radiation therapy were
identified from our local radiation oncology information
system. Inclusion criteria was limited to early stage disease
(Ia/b or IIa) measuring <5 cm in the largest dimension.
Furthermore, the gross tumour volume (GTV) was required
to be >2 cm away from the proximal bronchial tree.
Patients were simulated as previously reported.2 A
four-dimensional computed tomography (4DCT) scan
was acquired at the time of simulation along with a free-
breathing CT scan. Both scans were exported to Pinnacle
v9.4 (Philips Medical Systems, Fitchburg, WI) with the
4DCT used to generate an internal target volume (ITV).
The planning target volume (PTV) was created by
expanding the ITV 5 mm isotropically. The free-breathing
simulation CT scan was used for all OAR (Table 1)
contouring and treatment planning. All maximum doses
reported were to a clinically significant and measurable
volume of 0.03 cm3. The chest wall contour was defined
as a 2-cm expansion on the ipsilateral lung, excluding the
vertebral body, sternum and mediastinal structures. A
structure was also created for reporting the maximum
dose at any point 2 cm from the PTV (D2cm).
Treatment planning was carried out with Pinnacle v9.4
and the SmartArcTM algorithm. The final gantry spacing
option in Pinnacle allows for the treatment planner to
select the angular separation (in degrees) of the arc
segments. It has previously been reported that a gantry
spacing of 4° (new segment every 4°) is optimal, with no
benefit in reducing the spacing any further.8 In this study,
a full 360° arc will always have 91 segments with 0°, or
the starting angle, being included as a segment. The plans
were computed using an Elekta Axesse beam model with
the beam modulator collimator system with 4-mm MLC
leaves. A dose grid resolution of 0.25 cm3 was used for all
plans. All plans were calculated using the collapsed cone
convolution algorithm (CCC). The CCC algorithm is a
type B algorithm and accounts for changes in lateral
electron transport and should therefore be used for lung
tumour treatments. Treatment planning was performed
by a single planner and the machine quality assurance
was performed by a medical physicist to ensure the plans
were clinically deliverable with a gamma analysis passing
rate of 3 mm/3%.
Unlike 3DCRT where the isocentre is placed in the
centre of the PTV, the isocentre for the arc plans was
placed on the patient’s midline. This was to avoid any
further complications that could cause a collision, such as
when the bed is shifted laterally and is coupled with a
rotating gantry and non-coplanar floor angles. The
Table 1. Organ at risk dose constraints.
Organ Constraint(s)
Spinal cord 18 Gy < 0.35 cm3
12.3 Gy < 1.2 cm3
MPD < 21.9 Gy
Brachial plexus 20.4 Gy < 3 cm3
MPD < 24 Gy
Aorta, SVC and IVC 39 Gy < 10 cm3
MPD < 49 Gy
Pericardium 24 Gy < 15 cm3
MPD < 30 Gy
Trachea 15 Gy < 4 cm3
MPD < 30 Gy
Combined lungs – ITV 11.4 Gy < 1000 cm3
10.5 Gy < 1500 cm3
Oesophagus 17.7 Gy < 5 cm3
MPD < 25.2 Gy
Rib 40 Gy < 5 cm3
MPD < 50 Gy
Chestwall 30 Gy < 30 cm3
(<70 cm3 for tumours on the CW)
Skin 30 Gy < 10 cm3
MPD < 33 Gy
IVC, inferior vena cava; SVC, superior vena cava; ITV, internal target
volume; MPD, maximum point dose (defined as ≥0.03 cm3).
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isocentre could have been placed in the PTV for the
coplanar arcs but was left on the patient’s midline to
avoid any bias. All fields used 6 MV photons delivered
with a collimator angle of zero.
The single full arc (FA) technique started at 181°, and
travelled in a clockwise (CW) direction for 359° to stop
at 180°. The partial arc (PA) technique started at either
181° or 180° and travelled an arc length of 180–200°
around the ipsilateral side of the patient either in a CW
or counter-clockwise (CCW) direction. The non-coplanar
partial arc technique (NCA) used three partial arcs, one
with a couch angle of 0° and two using non-coplanar
couch angles. For left-sided tumours, the couch angles
were 0°, 15° and 340° and for right-sided tumours they
were 0°, 20° and 345°. These angles were chosen as they
were the greatest possible couch rotations away from zero
(allowing for less overlapping of beams, and reducing the
intermediate dose wash) without the gantry head and
couch colliding. The arc angles for the NCA technique
were the same as used for the PA technique. Multileaf
collimator speed was constrained to 0.46 cm/degree as
per department protocol.
A total dose of 54 Gy in 3 fractions was prescribed to
the periphery of the PTV ensuring that >95% of the PTV
received the prescription dose (PTV54Gy) and that 99% of
the PTV received 90% of the prescription dose
(PTV48.6Gy). The 54 Gy isodose (prescription isodose) was
planned to fall between 59% and 90% of the maximum
dose in the plan, resulting in a maximum dose of no
more than 91.5 Gy. Organ at risk tolerances used were
those reported in RTOG 1021 (Table 1). The constraints
to limit the intermediate doses, D2cm, the dose at any
point 2 cm from the PTV and the ratio of the volume of
half the prescription dose to the volume of the PTV
(R50%) are also shown in Table 2. To quantify the
conformity of the prescription isodose, the conformity
index (CI) was used2
ðTVPTVÞ2
TV PIV ;
where TVPTV is defined as the total volume of PTV
covered by the covering isodose (54 Gy), TV is defined as
the total volume of the PTV and PIV is defined as the
total volume of the covering isodose in the patient. A CI
value of ≥0.75 was no deviation, with ≥0.65 constituting
an acceptable deviation and anything <0.65 was
considered unacceptable. This CI formula was used
instead of the RTOG formula as it is more robust and
less prone to errors.
Each technique was created using the initial set of
objectives outlined in Table 3. Other objectives such as
the maximum dose to the spinal cord, pericardium, chest
wall, trachea and oesophagus were used on an individual
patient basis as necessary. As the dose being delivered to
the PTV is of an ablative nature, limiting the dose to
surrounding tissues directly adjacent to the PTV is
extremely important. Therefore, unlike conventional
intensity modulation, no expansion was made to the PTV
for dose optimisation. The objective used on the PTV was
a dose volume histogram (DVH) objective to cover a
minimum of 100% of the PTV with 54 Gy. To promote a
steep-dose gradient, a minimum and maximum dose
objective was used to control dose to the ITV. This
would ensure that the maximum dose would be between
60 Gy and 91.5 Gy, and that the 54 Gy isodose would fall
within 59–90% of the maximum dose. To control the
prescription dose, a ring with a 1 mm gap to the PTV
was created with a maximum dose objective equal to the
prescription dose. This gave the optimisation algorithm a
1 mm gap to place the 54 Gy isodose, ensuring a tight
and compact high- dose region. To limit the intermediate
dose, two different objective functions were used. First, a
structure constructed from the patients external contour
minus the PTV plus a 2-cm expansion was used to
control the dose at D2cm. This region of interest (ROI)
was given a maximum dose objective as per the relevant
values in the no deviation column for D2cm in Table 2.
Furthermore, to help meet the R50% (the value of half the
prescription dose divided by the volume of the PTV)
constraint (Table 2), a structure constructed from the
patients external contour minus an expansion on the
PTV was used to control the 27 Gy isodose. This
expansion was typically a 1-cm isotropic expansion of the
PTV based on the assumption that dose reduction of
5%/mm is achievable. The expansion on the PTV was
reduced/increased but was altered on an individual
patient basis as needed to better control the 27 Gy
isodose volume. The weights in the objective list were
chosen to first cover the entire PTV with 54 Gy isodose,
and then use the ring structures to control the
intermediate dose to meet the dose conformity
constraints. For PTVs adjacent to or overlapping the
chest wall, the allowable maximum dose to the rib was
increased to 105% of the prescription dose and recorded
as an acceptable deviation.
Statistical analyses were performed using R statistical
software (http://www.r-project.org). The three new SABR
treatment plans were compared using a repeated
measures ANOVA (parametric test) for normally
distributed data and the Friedman test (non-parametric
test) for non-normally distributed data. Normality of the
data has been tested using the Shapiro–Wilk test. When
an overall significant difference between treatment plans
was demonstrated, post hoc tests (paired t-tests for
normally distributed data or Wilcoxon signed-rank tests
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for non-normally distributed data) were performed to
confirm where the differences occurred between treatment
plans. The P-values have been adjusted for multiple
comparisons using false discovery rate (FDR) correction
to control the expected proportion of incorrectly rejected
null hypotheses. The P-values obtained have been
adjusted for multiple comparisons with a Bonferroni
correction. Statistical significance was defined as P ≤ 0.05.
Results
Mean PTV size was 32.3 cm3 with five of the ten patients
having tumours adjacent to the chest wall. Patient
characteristics are detailed in Table 4. Acceptable plans,
defined as having no major protocol deviations as
outlined in RTOG 1021 (Table 2), were obtained for
70%, 40% and 100% of the FA, PA and NCA techniques
respectively. A summary of the dosimetry parameters for
each technique are reported in Table 5.
PTV54Gy coverage was similar for the FA, PA and NCA
techniques achieving 95.09%, 95.11% and 95.71%
respectively. Coverage for the PTV48.6Gy objective was
99.97%, 99.92% and 99.99% for the FA, PA and NCA
respectively with a statistically significant difference
(P = 0.04) between the PA and NCA. The NCA
technique provided the best high dose conformity with a
value of 0.89, when compared to the FA (0.88) and PA
(0.82) techniques.
The NCA technique resulted in the highest compliance
with the no deviation criteria in Table 2. A previously
used scoring system for measuring the absolute difference
of the D2cm and R50% was used to evaluate the deviations
from an acceptable value.2 The mean absolute difference
from the R50% no deviation value (Table 2) was 1.04,
0.52 and 0.12 for the PA, FA and NCA techniques
respectively. The mean absolute difference from the D2cm
no deviation was of 5.33, 3.71 and 0.46 for the
NCA, FA and PA respectively. This resulted in a
statistically significant difference of 0.03 when comparing
the FA and PA, and P = 0.04 when comparing the NCA
and PA for the R50% constraint and <0.0001 for the D2cm
between all techniques. Figure 1 plots the achieved R50%
values against the PTV size for each of the ten patients.
Organ at risk sparing was similar among techniques
(Table 5). For doses to the combined lung minus the ITV
volume, the NCA reduced the 10.5 Gy wash by a mean
volume of 44 and 24 cm3 for the PA and FA technique,
respectively, and the 11.4 Gy dose wash by a mean
volume of 44 and 25 cm3 respectively. Spinal cord
maximum doses were lower with the NCA technique
(Table 5). The FA had 1 plan and the PA technique had
Table 2. Acceptable dose spillage guidelines from RTOG 1021.
Ratio of prescription isodose
volume to the PTV
Ratio of 27 Gy isodose
volume to the PTV (R50%)
Maximum dose at 2 cm from
PTV in any direction as % of
prescribed dose (PD). D2cm
(Gy) = % 9 PD
PTV volume (cc)
Deviation Deviation Deviation
None Acceptable None Acceptable None Acceptable
<1.2 <1.5 <5.9 <7.5 <50.0 <57.0 1.8
<1.2 <1.5 <5.5 <6.5 <50.0 <57.0 3.8
<1.2 <1.5 <5.1 <6.0 <50.0 <58.0 7.4
<1.2 <1.5 <4.7 <5.8 <50.0 <58.0 13.2
<1.2 <1.5 <4.5 <5.5 <54.0 <63.0 22.0
<1.2 <1.5 <4.3 <5.3 <58.0 <68.0 34.0
<1.2 <1.5 <4.0 <5.0 <62.0 <77.0 50.0
<1.2 <1.5 <3.5 <4.8 <66.0 <86.0 70.0
<1.2 <1.5 <3.3 <4.4 <70.0 <89.0 95.0
<1.2 <1.5 <3.1 <4.0 <73.0 <91.0 126.0
<1.2 <1.5 <2.9 <3.7 <77.0 <94.0 163.0
Table 3. List of starting objectives for all techniques.
ROI Objective type
Target
dose (Gy) Volume (%)1 Weight
PTV Minimum DVH 54 100 5
ITV Minimum dose 60 1
ITV Maximum dose 91.5 5
D2cm Maximum dose Table 2 5
27 Gy ring Maximum dose 27 5
54 Gy ring Maximum dose 54 1
ROI, region of interest; DVH, dose volume histogram.
1Only applicable for Maximum or Minimum DVH objective types.
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3 plans where the maximum dose to the ribs could not
be achieved. Conversely, the NCA technique was able to
achieve maximum rib doses for all 10 patients. The chest
wall volume receiving 30 Gy (V30Gy) ranged from 0 to
62.07, 0 to 52.36 and 0 to 53.30 cm3 for the PA, FA and
NCA techniques, respectively, for all ten patients. Where
the PTV was overlapping the chest wall, the mean V30Gy
was 35.79, 33.18 and 32.46 cm3 for the PA, FA and NCA
techniques respectively.
Discussion
This study presents an expansion on previous work where
the effects of non-coplanar beam arrangements for lung
SABR using 3DCRT were reported. Similar to those
findings with 3DCRT, the non-coplanar VMAT technique
tested in this study also provides greater compliance with
the RTOG 1021 protocol when compared to single arc
coplanar techniques.
The NCA technique provided the most optimal plan
with greater adherence to the RTOG 1021 guidelines than
the other two techniques. All 10 of the NCA treatment
plans adhered to RTOG 1021 protocol guidelines. The
technique that had the least compliance with the planning
objectives was the PA technique. Only 40% of the plans
were acceptable with a majority of the deviations being
associated with the intermediate dose constraints. Having
an arc only enter through a 180–200° sector did not
allow for enough low dose spread throughout the normal
tissue, resulting in higher than favourable intermediate
doses. The FA technique had 7 out of 10 plans which
were clinically acceptable. Of the three not acceptable, the
R50% was above an acceptable deviation in 2 plans and
the rib maximum dose was over tolerance in the other.
Similarly to Holt et al. , we also report that the CI for
the prescription isodose were within acceptable limits for
all techniques8. Holt et al. report a few exceptions to
achieving an optimal CI for the prescription dose. In this
study, we report no deviations to the CI regardless of
delivery technique. This could be due to a number of
different factors including the different CI equations used,
different treatment machine and contrasting intensity
modulation objectives. Furthermore, there was also an
improvement in the CI with the FA and NCA techniques,
which is largely due to the greater number of segments,
and therefore ‘individual beams’ used with the FA and
NCA techniques.
The OAR sparing was similar between each technique.
There was improved spinal cord sparing with the NCA
and PA technique which is due to the fact that neither of
these techniques had beams entering through the spinal
cord, an unavoidable consequence of the FA technique.
Furthermore, the NCA was able to improve both the
maximum dose and specific volumetric dose constraint
for all midline structures such as the aorta, trachea and
oesophagus. The NCA technique was able to either
achieve the constraint or limit the maximum rib dose to
acceptable deviation for all 10 patients. Furthermore, the
maximum V30Gy (62.07 cm
3) to the chest wall for the PA
technique was able to be reduced by almost 10 cm3
(52.36 and 53.33 cm3 for the FA and NCA, respectively)
by the other two techniques. Although still within the
70 cm3 constraint, this reduction in chest wall dose is
likely to be clinically significant, as reported by both Ong
et al. and Dunlap et al. where a V30Gy < 30 cm
3 could
reduce the risk of toxicity, especially if SABR offers an
improvement in long-term survival.4,9 The improvement
to OAR sparing could be due to the larger number of
control points for the NCA and FA techniques, and
therefore larger number of opportunities to shield out
OAR.
A universal issue arising from arc-based techniques is
the increased dose wash to the lungs, especially the
contralateral lung. Pre-established 3DCRT non-coplanar
techniques enter through the contralateral lung, however,
they are generally only from one or two static angles. The
Table 4. Patient characteristics.
Gender (n)
Male 7
Female 3
Age (years)
Range 61–83
Median 76
Mean 74.8
Staging
T1aN0M0 5
T1bN0M0 2
T1NOSN0M0 3
Location
RUL 5
RML 1
RLL 2
LUL 1
LLL 1
Overlapping with CW (n)
Yes 5
No 5
ITV size (cm3)
Range 4.43–29.9
Median 8.3
Mean 10.4
PTV size (cm3)
Range 22.8–79.12
Median 27.49
Mean 32.26
NOS, not specified; CW, chest wall; ITV, internal target volume; PTV,
planned target volume; RUL, right upper lobe; RML, right middle lobe;
RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.
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FA technique used in this study enters through the
entire contralateral lung, exposing more volume to a
lower dose. The effect of this can be seen with the
increase in the mean lung dose (MLD). Holt et al.
report a MLD of 4.2 Gy for single coplanar VMAT
which is on par with our result of an average MLD of
4.3 Gy).8 The reduction in MLD for the PA technique
is because a smaller volume of lung is receiving low
dose. Furthermore, dose is being deposited through
non-coplanar angles with the NCA technique, further
reducing the MLD. In a matched analysis study, Palma
et al. investigated radiobiological and clinical
pneumonitis after both VMAT (RapidArc) and 3DCRT
and concluded that there was no difference in the
severity of clinical or radiobiological sequelae after
treatment.10 Figure 2 displays the reduced dose wash to
Table 5. Mean dose statistics for each technique with associated P-values.
Metric Parameter PA FA NCA
P-value1
(PA-NCA)
P-value1
(FA-NCA)
PTV54Gy (%) 95.11 95.09 95.71 0.15 0.15
PTV48.6Gy (%) 99.92 99.97 99.99 0.04
D2cm Absolute difference 0.46 3.71 5.33 <0.0001 <0.0001
R50% Absolute difference 1.04 0.52 0.12 0.04 0.03
CI 0.83 0.88 0.89 0.06 0.23
MLD (Gy) 4.09 4.31 3.98 0.05 <0.0001
Spinal cord Dmax (Gy) 9.52 11.0 6.80
V18Gy (cm
3) 0.0 0.0 0.0
V12.3Gy (cm
3) 0.02 0.11 0.0
Rib Dmax (Gy) 45.45 43.3 42.75
V40Gy (cm
3) 1.55 1.40 1.47
Chest wall V30Gy (cm
3) 20.12 16.95 16.44
Combined Lung - ITV V10.5Gy (cm
3) 434.79 414.79 390.93
V11.4Gy (cm
3) 400.01 380.41 355.59
Pericardium Dmax (Gy) 19.53 19.91 18.46
V24Gy (cm
3) 1.93 1.49 0.52
Skin Dmax (Gy) 23.62 21.39 20.0
V30Gy (cm
3) 0.5 0.49 0.49
Oesophagus Dmax (Gy) 9.82 12.47 6.64
V17.7Gy (cm
3) 0.0 0.0 0.0
Aorta Dmax (Gy) 11.97 14.60 9.94
V39Gy (cm
3) 0.0 0.0 0.0
Trachea Dmax (Gy) 6.05 7.2 5.6
V15Gy (cm
3) 0.02 0.47 0.0
PA, coplanar partial arc technique; FA, coplanar full arc technique; NCA, non-coplanar technique utilising three partial arcs; ITV, internal target
volume; PTV, planned target volume; MLD, mean lung dose; CI, conformity index.
1Adjusted P value of post hoc tests.
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Figure 1. The R50% value achieved in the non-coplanar arc (NCA), partial arc (PA) and full arc (FA) techniques plotted against PTV size.
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the contralateral lung with both the PA and NCA
techniques when compared to the FA technique.
A general concern with intensity modulated treatments
for lung cancer is the interplay effect, which is the
potential difference in the planned dose to the delivered
dose. This is caused by differences in the MLC
movements to tumour motion when comparing the static
respiratory phase the planning CT captured with the
breathing cycle during treatment.11 Several groups have
investigated this phenomenon (VMAT or RapidArc) and
report that for a single fraction split over two arcs, or >1
treatment fractions, the interplay effect is negligible and
the actual delivered dose is within reasonable tolerance to
the planned dose.11–13
Although the NCA provides improved plan quality,
these small gains in intermediate dose reduction may be
of little importance in the current clinical setting. With
R50% and D2cm values achieved by the FA technique
within acceptable protocol deviations, the advantage of a
single coplanar arc may outweigh the improved
performance of non-coplanar techniques. In a clinical
setting where patients are generally from an older
population and may not tolerate long treatment times
and a high emphasis is placed on departmental efficiency,
the FA technique provides acceptable treatment plans in a
majority of cases and can be delivered in a shorter
treatment time. However, if the delivery of highly ablative
doses is beneficial to a younger cohort of patients
diagnosed with early stage lung cancer, increased
reduction in intermediate doses available with the NCA
may be of benefit. Furthermore, a coplanar arc technique
may better lead to advanced treatment techniques such as
dynamic MLC tracking or breath hold techniques where
quicker treatment times are a necessity.
Conclusion
The non-coplanar (NCA) VMAT technique utilising three
non-coplanar partial arcs produced optimal plans that
demonstrated better compliance with the dose constraints
NCA 
PA 
FA 
Figure 2. Isodose distribution for the non-coplanar arc (NCA), partial arc (PA) and fall arc (FA) techniques viewing in the transverse, sagittal and
coronal projections (from left to right).
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in the RTOG 1021 protocol when compared to the single
arc coplanar techniques. For those tumours entirely
encapsulated in lung parenchyma, full single arc coplanar
VMAT provided acceptable plans when accepting small
deviations to the intermediate dose constraints. Single FA
coplanar VMAT is a suitable treatment option for lung
SABR when intermediate and OAR doses are within
acceptable limits.
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